Study supports value of sigmoidoscopy, an alternative to colonoscopy

May 21, 2012 By Randy Dotinga, HealthDay Reporter
Study supports value of sigmoidoscopy, an alternative to colonoscopy
Research suggests the test can help prevent colon cancer incidence, deaths.

(HealthDay) -- New research confirms that sigmoidoscopies -- less-invasive alternatives to colonoscopies that don't require sedation -- are effective in lowering the risk of colon cancer.

Having the procedure lowered the risk of getting a colon by 21 percent and the chances of dying from the disease by 26 percent, the researchers reported.

Many doctors no longer offer sigmoidoscopies, but an editorial accompanying the study pointed out that sigmoidoscopies are still a good option for some patients.

"Physicians need to find out which colorectal cancer screening test the patient sitting in front of them will do, and recommend that test," said editorial author Dr. John Inadomi, a professor of medicine at the University of Washington School of Medicine in Seattle. "It's the test the patient wants to do -- not the test the doctor wants them to do -- that is important."

Colon and rectal cancers kill more than 51,000 people a year in the United States, according to the . Colonoscopies allow doctors to view the lining of the entire colon as they engage in search-and-destroy missions against polyps that could develop into cancer.

Sigmoidoscopies use a smaller scope that searches only the lower colon, potentially missing some . Patients can return to home or work right after the procedure because they are not sedated.

Both kinds of screening require a notoriously unpleasant cleansing of the colon via a liquid laxative. However, sigmoidoscopies require less laxative consumption than colonoscopies, Inadomi said.

But there is a hitch to sigmoidoscopies: If the procedure turns up potentially dangerous polyps, they need to be removed during a subsequent .

In the new study, researchers randomly assigned half of 154,900 people aged 55 to 74 to sigmoidoscopies -- 84 percent actually got them -- and tried to get those patients to return for a second three to five years later. The study lasted from 1993 to 2001.

The risk of deaths in the patients overall was small -- 593 occurred over an average of 12 years of follow-up. But the risk fell by 26 percent in those who had the procedures compared to people in the usual care group, who only got colonoscopies or sigmoidoscopies if they asked for one or their doctor recommended one. The researchers estimated that if they had used colonoscopies rather than sigmoidoscopies in their study, they would have spotted 16 percent more cancers.

However, the researchers discovered that even colonoscopies sometimes failed to find precancerous polyps.

When it comes to the ability of regular colonoscopies to detect polyps, "we may have to do better," said study author Dr. Robert Schoen, a professor of medicine and epidemiology at the University of Pittsburgh School of Medicine. "Or maybe we can't do better."

The study appears online May 21 in the New England Journal of Medicine, to coincide with a presentation at the annual Digestive Diseases Week meeting in Chicago.

Explore further: Study: Colonoscopy cuts colon cancer death risk

More information: For more about colon cancer, try the U.S. National Library of Medicine.

Related Stories

Study: Colonoscopy cuts colon cancer death risk

February 22, 2012
(AP) -- Millions of people have endured a colonoscopy, believing the dreaded exam may help keep them from dying of colon cancer. For the first time, a major study offers clear evidence that it does.

Study: Simple scope exam cuts colon cancer deaths

May 21, 2012
A simple, cheaper exam of just the lower part of the bowel can cut the risk of developing colon cancer or dying of the disease, a large federal study finds.

Poor colonoscopy prep hides pre-cancerous polyps

March 27, 2012
(Medical Xpress) -- What happens on the day before a colonoscopy may be just as important as the colon-screening test itself.

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.